Black Diamond Therapeutics, Inc. · NASDAQ:BDTX

BB Biotech AG's stake in Black Diamond Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)

Event Mar 19, 2025 · Filed Mar 21, 2025

BB Biotech AG's stake in Black Diamond Therapeutics, Inc. fell to 4.80%, 2,733,547 shares, as a passive investor on Mar 19, 2025. Filed Mar 21, 2025 (Schedule 13G/A).

Stake
4.80%
Shares
2,733,547
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
BB Biotech AG4.80%2,733,547
Biotech Growth N.V.4.80%2,733,547

Source

View original at SEC

Related